Advertisement

We need your help now

Support from readers like you keeps The Journal open.

You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.

If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.

jonny2love via Creative Commons

New link found between genes and pessimism

A new study has shown that levels of a certain chemical in your brain could predispose you to pessimism, stress and even depression.

PESSIMISM IS GENETIC according to a new study, which suggests levels of a certain chemical in the brain influences how we think and feel.

Those who are often told to ‘look on the bright side’ of things could have lower levels of a molecule called neuropeptide Y (NPY), which tends to make people view life without rose-coloured glasses. Those with low levels of the molecule tend to be more pessimistic and get stressed more easily.

More seriously, those with low levels of  NPY are also more likely to suffer from depression reports WebMD.

The Telegraph reports that researchers from the University of Michigan used functional magnetic resonance imaging (fMRI) to monitor the brain activity of volunteers as they were read words with neutral, positive or negative connotations. Those with low levels of NPY displayed greater activity in the prefrontal cortex – the area of the brain which deals with emotion.

Subjects were then given a pain challenge, in which they were required to recount a controlled painful experience. Volunteers were injected in the jaw with saline solution, which caused moderate pain for about 20 minutes but no lasting harm. They were then asked to rate the level of pain on a scale of one to 10.

Those with low levels of NPY were more negative both before and after the experience, meaning they were more emotionally affected by it.

Lastly, scientists compared the NPY genotypes of subjects with major depressive disorder with control subjects; they found that those with low levels of the molecule were more likely to suffer from a depressive illness.

See the full report in the Archives of General Psychiatry.

Readers like you are keeping these stories free for everyone...
A mix of advertising and supporting contributions helps keep paywalls away from valuable information like this article. Over 5,000 readers like you have already stepped up and support us with a monthly payment or a once-off donation.

Close
JournalTv
News in 60 seconds